An evaluation of ADIPOQ’s receptor PBMC expression levels showed that ADIPOR1 mRNA levels were decreased in CRC, while ADIPOR2 mRNA levels did not differ between the groups (Table 1). Here, ADIPOQ is linked to colorectal carcinoma.